Celularity Inc. Form DEF 14A: Definitive proxy statement
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2025-11-07: Form DEF 14A; Period of report 2025-11-07; Description DEF 14A; Document formdef14a.htm.
- 2024-11-19: Form DEF 14A; Period of report 2024-10-19; Description Definitive proxy statement; Document formdef14-a.htm.
- 2024-02-02: Form DEF 14A; Period of report 2024-02-02; Description Definitive proxy statement; Document formdef14a.htm.
- 2023-05-01: Form DEF 14A; Period of report 2023-06-14; Description DEF 14A; Document d484792ddef14a.htm.
| Filed | Form | Period of report | Description | Document |
|---|---|---|---|---|
| 2025-11-07 | DEF 14A | 2025-11-07 | DEF 14A | formdef14a.htm |
| 2024-11-19 | DEF 14A | 2024-10-19 | Definitive proxy statement | formdef14-a.htm |
| 2024-02-02 | DEF 14A | 2024-02-02 | Definitive proxy statement | formdef14a.htm |
| 2023-05-01 | DEF 14A | 2023-06-14 | DEF 14A | d484792ddef14a.htm |
| 2022-06-03 | DEF 14A | 2022-07-13 | DEF 14A | d338327ddef14a.htm |
| 2021-04-14 | DEF 14A | 2021-05-14 | DEFINITIVE PROXY STATEMENT | def14a0421_gxacq.htm |
| 2020-12-04 | DEF 14A | 2020-12-29 | DEFINITIVE PROXY STATEMENT | ea130892-def14a_gxacq.htm |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |